Patient Derived Xenografts (PDX) for personalized treatment of pancreatic cancer: emerging allies in the war on a devastating cancer?-Reference-Cited by-同舟云学术

Patient Derived Xenografts (PDX) for personalized treatment of pancreatic cancer: emerging allies in the war on a devastating cancer?

Published:2018-09 Issue: Volume:188 Page:107-118
ISSN:1874-3919
Container-title:Journal of Proteomics
language:en
Short-container-title:Journal of Proteomics

Author:

Sereti Evangelia,Karagianellou Theodosia,Kotsoni Ioanna,Magouliotis Dimitrios,Kamposioras Konstantinos,Ulukaya Engin,Sakellaridis Nikos,Zacharoulis Dimitrios,Dimas Konstantinos^ORCID

Publisher

Elsevier BV

Subject

Biochemistry,Biophysics

Reference110 articles.

1. Cancer statistics, 2014;Siegel;CA Cancer J. Clin.,2014

2. Global cancer statistics;Jemal;CA Cancer J. Clin.,2011

3. Diabetes mellitus and risk of pancreatic cancer: a meta-analysis of cohort studies;Ben;Eur. J. Cancer (Oxford, England: 1990),2011

4. Cigarette smoking and pancreatic cancer: an analysis from the International Pancreatic Cancer Case-Control Consortium (Panc4);Bosetti;Ann. Oncol.,2012

5. Pancreatitis and pancreatic cancer risk: a pooled analysis in the International Pancreatic Cancer Case-Control Consortium (PanC4);Duell;Ann. Oncol.,2012

Cited by 23 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Recent advances in lung cancer organoid (tumoroid) research (Review);Experimental and Therapeutic Medicine;2024-08-01

2. Development and Validation of a Simple and Reliable HPLC-UV Method for Determining Gemcitabine Levels: Application in Pharmacokinetic Analysis;Medicina;2024-05-25

3. Personalizing non-small cell lung cancer treatment through patient-derived xenograft models: preclinical and clinical factors for consideration;Clinical and Translational Oncology;2024-03-29

4. Utility of patient-derived xenografts to evaluate drug sensitivity and select optimal treatments for individual non-small-cell lung cancer patients;2024-01-19

5. Personalized medicine and new therapeutic approach in the treatment of pancreatic cancer;Recent Advances in Nanocarriers for Pancreatic Cancer Therapy;2024